Delivery Order V797D70102-36C26023F0431
Award Date
8/2/23
Potential Completion Date
12/31/23
Potential Value
$78K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Vanda Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20037, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Vanda Pharmaceuticals Inc., a for-profit pharmaceutical manufacturer, by the U.S. Department of Veterans Affairs (VA). The contract, which is not set aside, is a delivery order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with a ceiling value of $154,048.79 and a performance period through December 31, 2024. Vanda Pharmaceuticals is the sole manufacturer of HETLIOZ (tasimelteon), a specialized medication used to treat...
This federal contract award is for the delivery of HETLIOZ (tasimelteon), a pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to the prime contractor, Vanda Pharmaceuticals Inc., doing business as Vanda, on October 1, 2024. The contract has a ceiling value of $162,771.05 and a performance period extending through September 30, 2025. This award is a delivery order placed against Vanda's existing GSA Federal Supply Schedule contract for...
This federal contract award is for the delivery of Hetlioz (tasimelteon), a treatment for Non-24-Hour Sleep-Wake Disorder, to the Department of Veterans Affairs (VA). The prime contractor is Vanda Pharmaceuticals Inc., doing business as Vanda, a global biopharmaceutical company. The contract was awarded as a Blanket Purchase Agreement (BPA) call against Vanda's Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract, with a potential value of $220,629.46. The contract...
This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences, LLC, a pharmaceutical company that specializes in medications for rare neurological diseases and sleep disorders. The contract is for the supply of WAKIX (pitolisant) 17.8 mg tablets, a treatment for excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract was issued against the VA's Pharmaceuticals and Drugs Federal Supply Schedule...
This is a firm fixed-price delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications to treat rare neurological diseases and sleep disorders. The award is for the supply of WAKIX (pitolisant) tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract has a ceiling value of...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company specializing in rare neurological diseases and sleep disorders. The contract, valued at $20,340, is for the supply of WAKIX (pitolisant) tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract was placed against Harmony Biosciences' General...
This is a firm-fixed-price delivery order awarded to Harmony Biosciences, LLC by the Department of Veterans Affairs (VA) Veterans Health Administration. The order is against the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has a ceiling value of $30,510.72. The order is for the supply of PITOLISANT (WAKIX) 17.8MG TAB NDC: 72028-0178-03, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. Harmony Biosciences is a...
This federal contract award was issued by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs (VA) to Harmony Biosciences LLC, a pharmaceutical company specializing in rare neurological diseases and sleep disorders. The $10,170 firm-fixed-price delivery order is for WAKIX 17.8 MG, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract is issued against Harmony Biosciences' General Services...
This federal contract award is a delivery order valued at $656,342.82 issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Harmony Biosciences LLC, a pharmaceutical company that specializes in developing and manufacturing medications for rare neurological diseases and sleep disorders. The award is for the bulk order of WAKIX (pitolisant) tablets, a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. Harmony...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order to Harmony Biosciences LLC, a for-profit pharmaceutical company, to provide WAKIX 17.8 MG tablets. The $10,170 order was placed against the VA's Pharmaceuticals and Drugs Federal Supply Schedule contract to support the delivery of this narcolepsy medication to VA locations in Pittsburgh, Pennsylvania, with a completion date of March 29, 2024. No set-aside provisions were used for this...